Oxford Biomedica JP Morgan Global Healthcare Conference 2024

Oxford Biomedica is a leading Contract Development and Manufacturing Organization (CDMO) specializing in viral vector manufacturing for cell and gene therapies. The company provides comprehensive manufacturing services across lentiviral, adenovirus, and AAV platforms, serving over 500 biotechs and major pharmaceutical partners. With proven expertise in large-scale commercial manufacturing and long-term partnerships including Novartis and Oxford AstraZeneca, OXB is positioned to capitalize on strong double-digit growth forecasted in the viral vector outsourced supply market.